| Particulars |
|
|
|
|
Company Name
| Shukra Pharmaceuticals Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
43.96 |
B.V. (₹) |
2.20 |
| Sales(₹ Cr.) |
56.71 |
NP (₹ Cr.) |
22.05 |
| NP Var% |
130.00 |
Div% |
1.00 |
| CPS(₹) |
0.60 |
EPS (₹) |
0.50 |
| Traded Value(₹ Lakhs) |
94.07 |
52 Week High |
65.00 |
| 52 Week Low |
23.00 |
Price BSE |
44.00 |
| Price NSE |
44.00 |
Market Capital (₹ Cr.) |
1,940.02 |
| P/C Ratio |
75.90 |
P/E Ratio |
87.70 |
| Price Vs.BV |
20.00 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
23.52 |
| NP(₹ Cr.) |
15.03 |
NP Var % |
1,360.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
38.51 |
| OPM |
40.12 |
NP |
14.43 |
| NP Var% |
256.21 |
EPS |
0.82 |
| PE |
53.82 |
|
|